Xi Chen

15PUBLICATIONS
118CO-AUTHORS
Predictive and prognostic markersHaematologyInnate immunityMedical devicesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 27, 2025
NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitors.

Ze-Yi Zheng, Anran Chen, Eric J Jaehnig

|Jan 09, 2025
IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs.

Brendan M Barton, Francheska Son, Akanksha Verma

|Dec 16, 2024
Development of a RIPK1 degrader to enhance antitumor immunity.

Xin Yu, Dong Lu, Xiaoli Qi

|Apr 25, 2024
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity.

Jin Wang, Dong Lu, Xin Yu

|Sep 07, 2023
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors.

Xiangdong Lv, Xuan Lu, Jin Cao

Pageof 3